Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
GNMSF

Genmab

$190.75

2.75 (1.46%)

, JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

17:29
01/19/18
01/19
17:29
01/19/18
17:29
Hot Stocks
Genmab says FDA grants priority review for daratumumab »

Genmab (GNMSF) announced…

GNMSF

Genmab

$190.75

2.75 (1.46%)

JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

ENDP

Endo

$7.11

-0.24 (-3.27%)

, CVS

CVS Health

$79.85

0.5 (0.63%)

16:15
01/19/18
01/19
16:15
01/19/18
16:15
Periodicals
Delaware files lawsuit against opioid manufacturers, distributors, Reuters says »

Delaware has become the…

ENDP

Endo

$7.11

-0.24 (-3.27%)

CVS

CVS Health

$79.85

0.5 (0.63%)

WBA

Walgreens Boots Alliance

$76.47

0.47 (0.62%)

MCK

McKesson

$170.33

-1.45 (-0.84%)

CAH

Cardinal Health

$71.90

0.19 (0.26%)

ABC

AmerisourceBergen

$100.01

-0.85 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 06

    Feb

  • 08

    Feb

TEVA

Teva

$20.90

0.185 (0.89%)

, MYL

Mylan

$46.51

-0.27 (-0.58%)

11:30
01/19/18
01/19
11:30
01/19/18
11:30
Periodicals
DOJ official says U.S. may sue generic drugmakers, Bloomberg reports »

Bloomberg cites the…

TEVA

Teva

$20.90

0.185 (0.89%)

MYL

Mylan

$46.51

-0.27 (-0.58%)

ENDP

Endo

$7.35

-0.34 (-4.42%)

LCI

Lannett

$24.55

0.9 (3.81%)

PRGO

Perrigo

$91.03

-0.66 (-0.72%)

AKRX

Akorn

$33.06

-0.09 (-0.27%)

TARO

Taro Pharmaceutical

$104.99

-2.275 (-2.12%)

IPXL

Impax

$20.55

0.15 (0.74%)

NVS

Novartis

$86.47

0.06 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 08

    Feb

  • 16

    Feb

  • 01

    Mar

  • 02

    Mar

  • 08

    Mar

  • 23

    Apr

  • 17

    May

  • 21

    Jul

Yesterday
TEVA

Teva

$20.88

-0.6 (-2.79%)

13:06
01/18/18
01/18
13:06
01/18/18
13:06
Downgrade
Teva rating change  »

Follow-up: Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$20.81

-0.67 (-3.12%)

13:00
01/18/18
01/18
13:00
01/18/18
13:00
Downgrade
Teva rating change at BTIG »

Teva downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$20.95

-0.535 (-2.49%)

, MYL

Mylan

$46.78

0.14 (0.30%)

11:34
01/18/18
01/18
11:34
01/18/18
11:34
Recommendations
Teva, Mylan, Impax, Novartis, Endo analyst commentary at Leerink »

Hospitals' entrant…

TEVA

Teva

$20.95

-0.535 (-2.49%)

MYL

Mylan

$46.78

0.14 (0.30%)

IPXL

Impax

$20.40

1.1 (5.70%)

NVS

Novartis

$86.43

-0.45 (-0.52%)

ENDP

Endo

$7.69

-0.32 (-4.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 08

    Feb

  • 16

    Feb

  • 01

    Mar

  • 08

    Mar

  • 23

    Apr

  • 17

    May

ENDP

Endo

$7.69

-0.32 (-4.00%)

, IPXL

Impax

$20.40

1.1 (5.70%)

11:19
01/18/18
01/18
11:19
01/18/18
11:19
Recommendations
Endo, Impax, Mylan, Teva analyst commentary at Cantor Fitzgerald »

Report of hospital plans…

ENDP

Endo

$7.69

-0.32 (-4.00%)

IPXL

Impax

$20.40

1.1 (5.70%)

MYL

Mylan

$46.78

0.14 (0.30%)

TEVA

Teva

$20.83

-0.65 (-3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 01

    Mar

  • 08

    Mar

TEVA

Teva

$20.63

-0.85 (-3.96%)

, MYL

Mylan

$46.78

0.14 (0.30%)

10:03
01/18/18
01/18
10:03
01/18/18
10:03
Periodicals
Hospitals plan nonprofit generic drug company, NY Times says »

Some of the…

TEVA

Teva

$20.63

-0.85 (-3.96%)

MYL

Mylan

$46.78

0.14 (0.30%)

ENDP

Endo

$7.69

-0.32 (-4.00%)

NVS

Novartis

$86.53

-0.35 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 08

    Feb

  • 16

    Feb

  • 08

    Mar

  • 23

    Apr

  • 17

    May

JNJ

Johnson & Johnson

09:29
01/18/18
01/18
09:29
01/18/18
09:29
Recommendations
Johnson & Johnson analyst commentary at Morgan Stanley »

Zytiga ruling a headwind,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

GILD

Gilead

$81.74

1.49 (1.86%)

, PFE

Pfizer

$37.18

0.58 (1.58%)

08:33
01/18/18
01/18
08:33
01/18/18
08:33
Hot Stocks
Kite, Pfizer to collaborate to evaluate combination of Yescarta, utomilumab »

Kite, a Gilead Company…

GILD

Gilead

$81.74

1.49 (1.86%)

PFE

Pfizer

$37.18

0.58 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 30

    Jan

  • 06

    Feb

  • 08

    Feb

  • 12

    Feb

  • 16

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.